27: STATUS EPILEPTICUS AFTER C-4 INGESTION USING LIQUID CHROMATOGRAPHY TO QUANTIFY TOXICITY
Sign Up to like & getrecommendations! Published in 2018 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000528083.00750.ad
Abstract: Learning Objectives: The effect of anti-hypertensive medications within the first 24 hours of acute ischemic stroke (AIS) in patients who received recombinant tissue plasminogen activator (rtPA) on prognosis and hospital course has not been evaluated.… read more here.
Keywords: disability death; ais patients; htn group; anti htn ... See more keywords
Abstract P181: Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control (OPTI-BP): A Pilot Study Utilizing a Smartphone App
Sign Up to like & getrecommendations! Published in 2019 at "Hypertension"
DOI: 10.1161/hyp.74.suppl_1.p181
Abstract: Background: About half of patients with hypertension (HTN) respond to any given antihypertensive drug. Discordance in pathophysiologic pathways underlying HTN and anti-HTN mechanism of action are major contributors. Personalizing anti-HTN therapy could optimize blood pressure… read more here.
Keywords: app recommendations; smartphone app; hypertension; htn ... See more keywords
Risk of hypertension in patients with CLL/SLL who participated in ALPINE: A post hoc analysis.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e19016
Abstract: e19016 Background: Bruton tyrosine kinase (BTK) inhibitors are an important therapeutic option for patients with CLL/SLL. The first-generation BTK inhibitor, ibrutinib (ibru), is associated with an increased risk of hypertension. Zanubrutinib (zanu) is a next-generation… read more here.
Keywords: patients cll; anti htn; risk; cll sll ... See more keywords
Factors affecting the changes in antihypertensive medications in patients with hypertension
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.999548
Abstract: As frequent changes in anti-hypertensive (HTN) medications may reduce adherence to the treatments, identifying modifiable factors leading to changes in anti-HTN medications can help clinicians optimize treatment strategies for individual patients. We performed this study… read more here.
Keywords: factors affecting; affecting changes; htn medications; anti htn ... See more keywords